Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fospropofol vs Propofol for Sedation in ICU Patients
NCT05491278Phase 2Completed
- Start
- Aug 2022
- Primary completion
- Jun 2023
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of fospropofol disodium in critical illness (2 arms). Primary endpoint: Percentage of time spent reaching sedation goals at 7 days. Started Aug 2022; status: completed.
02
Drugs
fospropofol disodium
03
Conditions
critical illness
Beyond the preview
Go deeper on NCT05491278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05491278.